• No CET Points

     


    In this edition of Advances in Eyecare, we hear from four experts about developments in treatments, assessments and our understanding of human vision. 

    Prof John Flanagan talks about a potential new treatment for glaucoma and explains the neuroprotective role of lipoxin around ganglion cells and how maintenance of this may offer new options in management of the disease.

    Dr Kathleen Vancleef discusses the ASTEROID project’s new technology, and how its new methodology promises to make the assessment of younger patients easier. 

    Dr Vivek Nityananda offers a unique insight into how we may better understand human stereo vision through his research into the stereo vision of praying mantises as part of the ‘Man, mantis and machine: the computation of 3D vision’ project.

    Prof Jenny Read, Principal Investigator on the ASTEROID project and ‘Man, mantis and machine: the computation of 3D vision’, talks virtual reality and 3D displays, and the potential impact of prolonged use of virtual reality displays upon the visual system.


      • 1.1.2 Understand the underlying lipoxin-mediated process in glaucoma and neurodegenerative disorders such as Alzheimer's disease and understand its likely influence upon future intervention in treatment.
      • 2.5.3 Understand the latest research about the pathophysiology of glaucoma and neurodegenerative disease so to be better able to inform patients and adapt practice as they impact in future.
      • 6.1.8 Understand the underlying physiological changes at neuronal level in glaucoma, which may progress independent of IOP changes, and so be better able to assess and explain both current disease progress and the implications for future treatments.
      • 8.1.1 Understand the limitations of current stereopsis tests and the benefits of newly developing digital display alternatives.

       
      Unit 1 - Lipoxins in the treatment of glaucoma (~11 mins)